Lifecore Biomedical Inc. (NASDAQ: LFCR)
$7.3200
+0.3400 ( +2.52% ) 90.3K
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Market Data
Open
$7.3200
Previous close
$6.9800
Volume
90.3K
Market cap
$213.22M
Day range
$6.9650 - $7.4550
52 week range
$3.6793 - $8.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 30, 2024 |
8-k | 8K-related | 15 | Apr 19, 2024 |
nt | Quarterly Reports | 1 | Apr 08, 2024 |
8-k | 8K-related | 48 | Apr 01, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
8-k | 8K-related | 18 | Mar 21, 2024 |
8-k | 8K-related | 20 | Mar 20, 2024 |
10-k | Annual reports | 175 | Mar 20, 2024 |
8-k | 8K-related | 15 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |